Literature DB >> 21187321

Galectin-9 regulates T helper cell function independently of Tim-3.

Ee W Su1, Shuguang Bi, Lawrence P Kane.   

Abstract

β-Galactoside-binding lectin 9 (galectin-9) is a tandem repeat-type member of the galectin family. It was initially characterized as an eosinophil chemoattractant and an inducer of apoptosis in thymocytes. Subsequently, galectin-9 was identified as a ligand for transmembrane immunoglobulin mucin domain 3 (Tim-3), a type I glycoprotein induced on T cells during chronic inflammation. Work in autoimmune diseases and chronic viral infections have led to the current hypothesis that the function of Tim-3 is to limit immune responses. However, it is still not known to what degree these effects are due to the galectin-9/Tim-3 interaction. In this study, we show that galectin-9 is not limited to the role of a pro-apoptotic agent, but that it can also induce the production of pro-inflammatory cytokines from T helper cells. This effect is dose-dependent and does not require Tim-3. These findings suggest that the effects of galectin-9 on T cells are more complex than previously thought and are mediated by additional receptors apart from Tim-3.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21187321      PMCID: PMC3167474          DOI: 10.1093/glycob/cwq214

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  28 in total

1.  A novel transcription factor, T-bet, directs Th1 lineage commitment.

Authors:  S J Szabo; S T Kim; G L Costa; X Zhang; C G Fathman; L H Glimcher
Journal:  Cell       Date:  2000-03-17       Impact factor: 41.582

2.  Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance.

Authors:  Catherine A Sabatos; Sumone Chakravarti; Eugene Cha; Anna Schubart; Alberto Sánchez-Fueyo; Xin Xiao Zheng; Anthony J Coyle; Terry B Strom; Gordon J Freeman; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2003-10-12       Impact factor: 25.606

3.  Regulation of galectin-9 expression and release in Jurkat T cell line cells.

Authors:  Sophie Chabot; Yumiko Kashio; Masako Seki; Yukako Shirato; Kazuhiro Nakamura; Nozomu Nishi; Takanori Nakamura; Ryoji Matsumoto; Mitsuomi Hirashima
Journal:  Glycobiology       Date:  2002-02       Impact factor: 4.313

4.  Tim-3/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells.

Authors:  Valerie Dardalhon; Ana C Anderson; Jozsef Karman; Lionel Apetoh; Rucha Chandwaskar; David H Lee; Melanie Cornejo; Nozomu Nishi; Akira Yamauchi; Francisco J Quintana; Raymond A Sobel; Mitsuomi Hirashima; Vijay K Kuchroo
Journal:  J Immunol       Date:  2010-06-23       Impact factor: 5.422

5.  Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1.

Authors:  K E Pace; C Lee; P L Stewart; L G Baum
Journal:  J Immunol       Date:  1999-10-01       Impact factor: 5.422

6.  Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin.

Authors:  J Wada; K Ota; A Kumar; E I Wallner; Y S Kanwar
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

7.  Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance.

Authors:  Alberto Sánchez-Fueyo; Jane Tian; Dominic Picarella; Christoph Domenig; Xin Xiao Zheng; Catherine A Sabatos; Natasha Manlongat; Orissa Bender; Thomas Kamradt; Vijay K Kuchroo; José-Carlos Gutiérrez-Ramos; Anthony J Coyle; Terry B Strom
Journal:  Nat Immunol       Date:  2003-10-12       Impact factor: 25.606

8.  A proline-rich motif in the C terminus of Akt contributes to its localization in the immunological synapse.

Authors:  Lawrence P Kane; Marianne N Mollenauer; Arthur Weiss
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

9.  Specificity of binding of three soluble rat lung lectins to substituted and unsubstituted mammalian beta-galactosides.

Authors:  H Leffler; S H Barondes
Journal:  J Biol Chem       Date:  1986-08-05       Impact factor: 5.157

Review 10.  Galectin-9 in physiological and pathological conditions.

Authors:  Mitsuomi Hirashima; Yumiko Kashio; Nozomu Nishi; Akira Yamauchi; Tada-atsu Imaizumi; Toshiro Kageshita; Naoki Saita; Takanori Nakamura
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

View more
  50 in total

1.  Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs.

Authors:  Shipra Gupta; Thomas B Thornley; Wenda Gao; Rafael Larocca; Laurence A Turka; Vijay K Kuchroo; Terry B Strom
Journal:  J Clin Invest       Date:  2012-06-11       Impact factor: 14.808

2.  Acute stimulation generates Tim-3-expressing T helper type 1 CD4 T cells that persist in vivo and show enhanced effector function.

Authors:  Jacob V Gorman; John D Colgan
Journal:  Immunology       Date:  2018-02-08       Impact factor: 7.397

3.  TIM-3 Regulates CD103+ Dendritic Cell Function and Response to Chemotherapy in Breast Cancer.

Authors:  Álvaro de Mingo Pulido; Alycia Gardner; Shandi Hiebler; Hatem Soliman; Hope S Rugo; Matthew F Krummel; Lisa M Coussens; Brian Ruffell
Journal:  Cancer Cell       Date:  2018-01-08       Impact factor: 31.743

4.  CD206-positive myeloid cells bind galectin-9 and promote a tumor-supportive microenvironment.

Authors:  Elizabeth Ann L Enninga; Kyriakos Chatzopoulos; John T Butterfield; Shari L Sutor; Alexey A Leontovich; Wendy K Nevala; Thomas J Flotte; Svetomir N Markovic
Journal:  J Pathol       Date:  2018-06-28       Impact factor: 7.996

Review 5.  A review of the importance of immune responses in luminal B breast cancer.

Authors:  Delia J Nelson; Briony Clark; Kylie Munyard; Vincent Williams; David Groth; Jespal Gill; Henry Preston; Arlene Chan
Journal:  Oncoimmunology       Date:  2017-01-19       Impact factor: 8.110

6.  Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells.

Authors:  Chuan Wu; Theresa Thalhamer; Rafael F Franca; Sheng Xiao; Chao Wang; Chie Hotta; Chen Zhu; Mitsuomi Hirashima; Ana C Anderson; Vijay K Kuchroo
Journal:  Immunity       Date:  2014-07-24       Impact factor: 31.745

7.  Tim-3 regulates pro- and anti-inflammatory cytokine expression in human CD14+ monocytes.

Authors:  Ying Zhang; Cheng J Ma; Jia M Wang; Xiao J Ji; Xiao Y Wu; Jonathan P Moorman; Zhi Q Yao
Journal:  J Leukoc Biol       Date:  2011-08-15       Impact factor: 4.962

8.  Exosome-derived galectin-9 may be a novel predictor of rejection and prognosis after liver transplantation.

Authors:  Ai-Bin Zhang; Yi-Fan Peng; Jun-Jun Jia; Yu Nie; Shi-Yu Zhang; Hai-Yang Xie; Lin Zhou; Shu-Sen Zheng
Journal:  J Zhejiang Univ Sci B       Date:  2019-07       Impact factor: 3.066

9.  A TIM-3 Oligonucleotide Aptamer Enhances T Cell Functions and Potentiates Tumor Immunity in Mice.

Authors:  Tal Gefen; Iris Castro; Darija Muharemagic; Yvonne Puplampu-Dove; Shradha Patel; Eli Gilboa
Journal:  Mol Ther       Date:  2017-08-08       Impact factor: 11.454

10.  Galectin-9 modulates immunity by promoting Th2/M2 differentiation and impacts survival in patients with metastatic melanoma.

Authors:  Elizabeth Ann L Enninga; Wendy K Nevala; Shernan G Holtan; Alexey A Leontovich; Svetomir N Markovic
Journal:  Melanoma Res       Date:  2016-10       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.